Strides Pharma Science Limited

Strides Pharma Science Limited has informed the Exchange regarding a press release dated October 29, 2026, titled “Strides Delivers Strong Performance with Q2FY27 Revenue at ₹14,297m, Grew 17% YoYEx-US Markets Up 31% YoY; EBITDA Up 8% YoY to ₹2,509m, Crossing ₹2,500m in a Quarter for the First Time”|SUBJECT: Press Release



Source link